Screening and validating the prognostic biomarkers of hepatocelluar carcinoma based on reverse phase protein arrays / 中华肝胆外科杂志

ABSTRACT

Objective To screen and validate the prognostic biomarkers of patients with hepatocelluar carcinoma (HCC) based on reverse phase protein array (RPPA).Methods All public RPPA data (HCC patients) in TCGA database before December 2017 were enrolled in this study.Univariate and multivariate Cox analysis were used to screen the target proteins with prognostic value.From January 2013 to January 2014,121 HCC patients who were treated in the Affiliated Hospital of North Sichuan Medical College were enrolled in the study.Prognostic related proteins screened from RPPA data were detected in these patients' tumor specimen.Then,the correlations between the expression of the screened protein and prognosis was further analyzed.Results In the 218 protein,23 was related with HCC patient prognosis.Multivariate Cox regression analysis showed that high expression of NOTCH1 (HR=1.515,95％ CI1.287～1.845,P＜0.05) and high expression of AKT1 (HR=1.119,95％ CI1.033～ 1.203,P＜0.05) increased the risk of death,while high expression of NF2 (HR=0.865,95％ CI0.783～0.956,P＜0.05) decreased the risk of death.The results of clinical data analysis indicated that there were significant differences of NOTCH1,AKT1 and NF2 level between HCC and adjacent tissue.Further survival analysis revealed that high expression of NOTCH1 and AKT1 were significantly associated with poor prognosis.The expression of NF2 was correlated with prognosis,but the difference was not statistically significant (P＞0.05).Conclusion RPPA,as a high throughput protein expression quantitative technique,can be used for screening prognostic markers,and the reliability of the screening results is higher in general.